| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
19.30(B) |
| Last
Volume: |
1,320,173 |
Avg
Vol: |
2,032,990 |
| 52
Week Range: |
$52.73 - $75.19 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 411 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
5,445 |
5,445 |
| Total Buy Value |
$0 |
$0 |
$300,760 |
$300,760 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
7,402 |
145,760 |
145,760 |
343,516 |
| Total Sell Value |
$540,864 |
$9,806,982 |
$9,806,982 |
$25,333,278 |
| Total People Sold |
1 |
2 |
2 |
9 |
| Total Sell Transactions |
1 |
2 |
2 |
14 |
| End Date |
2025-09-28 |
2025-06-27 |
2024-12-27 |
2023-12-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Schnittker Brandon |
President, GYN Surgical |
|
2025-12-12 |
4 |
D |
$75.00 |
$6,750 |
D/D |
(90) |
17,512 |
|
- |
|
Liddy Anne M. |
General Counsel |
|
2025-11-14 |
4 |
D |
$74.15 |
$24,989 |
D/D |
(337) |
28,237 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2025-11-14 |
4 |
D |
$74.15 |
$13,866 |
D/D |
(187) |
17,884 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2025-11-14 |
4 |
D |
$74.15 |
$14,533 |
D/D |
(196) |
134,039 |
|
- |
|
Mitchell Essex D |
Chief Operating Officer |
|
2025-11-14 |
4 |
D |
$74.15 |
$99,509 |
D/D |
(1,342) |
77,610 |
|
- |
|
Schnittker Brandon |
President, GYN Surgical |
|
2025-11-14 |
4 |
D |
$74.15 |
$13,199 |
D/D |
(178) |
17,602 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2025-11-14 |
4 |
D |
$74.15 |
$98,842 |
D/D |
(1,333) |
150,735 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2025-11-14 |
4 |
D |
$74.15 |
$509,707 |
D/D |
(6,874) |
1,423,837 |
|
- |
|
Schneiders Jennifer M |
President, Diag. Solutions |
|
2025-11-14 |
4 |
D |
$74.15 |
$41,598 |
D/D |
(561) |
41,318 |
|
- |
|
Schnittker Brandon |
President, GYN Surgical |
|
2025-11-11 |
4 |
D |
$74.60 |
$21,559 |
D/D |
(289) |
17,780 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2025-11-11 |
4 |
D |
$74.60 |
$498,253 |
D/D |
(6,679) |
1,430,711 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2025-11-11 |
4 |
D |
$74.60 |
$13,279 |
D/D |
(178) |
134,235 |
|
- |
|
Schneiders Jennifer M |
President, Diag. Solutions |
|
2025-11-11 |
4 |
D |
$74.60 |
$52,369 |
D/D |
(702) |
41,879 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2025-11-11 |
4 |
D |
$74.60 |
$108,095 |
D/D |
(1,449) |
152,068 |
|
- |
|
Mitchell Essex D |
Chief Operating Officer |
|
2025-11-11 |
4 |
D |
$74.60 |
$126,895 |
D/D |
(1,701) |
78,952 |
|
- |
|
Liddy Anne M. |
General Counsel |
|
2025-11-11 |
4 |
D |
$74.60 |
$30,288 |
D/D |
(406) |
28,574 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2025-11-11 |
4 |
D |
$74.60 |
$13,503 |
D/D |
(181) |
18,071 |
|
- |
|
Schnittker Brandon |
President, GYN Surgical |
|
2025-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,113 |
18,069 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2025-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
169,582 |
1,437,390 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2025-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,823 |
134,413 |
|
- |
|
Horvath Mark W. |
President, Breast & Skeletal |
|
2025-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
13,458 |
23,139 |
|
- |
|
Schneiders Jennifer M |
President, Diag. Solutions |
|
2025-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
30,282 |
42,581 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2025-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
43,741 |
153,517 |
|
- |
|
Mitchell Essex D |
Chief Operating Officer |
|
2025-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
47,106 |
80,653 |
|
- |
|
Liddy Anne M. |
General Counsel |
|
2025-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,496 |
28,980 |
|
- |
|
765 Records found
|
|
Page 1 of 31 |
|
|